Inventor · disambiguated record
David Brent Rawlins
Also filed as: RAWLINS DAVID B · RAWLINS DAVID BRENT
19 granted patents·4 pending applications·399 citations·filing 1998–2018
95Inventor score
Files withBRISTOL MYERS SQUIBB CO8LEXICON PHARMACEUTICALS INC8HARRISON BRYCE ALDEN3BURGOON HUGH ALFRED2GOODWIN NICOLE CATHLEEN1
Top patents by PatentIndex Score
23 records- 0194US6720347B2Carbon substituted aminothiazole inhibitors of cyclin dependent kinasesBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Apr 13, 2004·32 cites·2 claims
- 0293US7781577B2Inhibitors of sodium glucose co-transporter 2 and methods of their useLEXICON PHARMACEUTICALS INC·Filed 2007·Granted Aug 24, 2010·18 cites·27 claims
- 0391US7846945B2Piperdine-based inhibitors of sodium glucose co-transporter 2 and methods of their useLEXICON PHARMACEUTICALS INC·Filed 2008·Granted Dec 7, 2010·10 cites·33 claims
- 0489US6262096B1Aminothiazole inhibitors of cyclin dependent kinasesBRISTOL MYERS SQUIBB CO·Filed 1999·Granted Jul 17, 2001·81 cites·1 claims
- 0588US6107305AUse of pyrazolo [3,4-b] pyridine as cyclin dependent kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 1998·Granted Aug 22, 2000·88 cites·26 claims
- 0688US6040321AAminothiazole inhibitors of cyclin dependent kinasesBRISTOL MYERS SQUIBB CO·Filed 1998·Granted Mar 21, 2000·85 cites·45 claims
- 0787US10106569B2Inhibitors of sodium glucose transporter 1 for constipationLEXICON PHARMACEUTICALS INC·Filed 2017·Granted Oct 23, 2018·5 cites·1 claims
- 0887US9688710B2Inhibitors of sodium glucose cotransporter 1LEXICON PHARMACEUTICALS INC·Filed 2015·Granted Jun 27, 2017·5 cites·8 claims
- 0985US9200025B2Inhibitors of sodium glucose cotransporter 1LEXICON PHARMACEUTICALS INC·Filed 2013·Granted Dec 1, 2015·7 cites·15 claims
- 1084US7423043B24-Piperidin-1-yl-7H-pyrrolo[2,3-d]pyrimidine compoundsLEXICON PHARMACEUTICALS INC·Filed 2006·Granted Sep 9, 2008·7 cites·18 claims
- 1183US6407124B1Carbon substituted aminothiazole inhibitors of cyclin dependent kinasesBRISTOL MYERS SQUIBB CO·Filed 1999·Granted Jun 18, 2002·26 cites·9 claims
- 1281US8476413B2Sulfanyl-tetrahydropyran-based compounds and methods of their useHARRISON BRYCE ALDEN·Filed 2010·Granted Jul 2, 2013·4 cites·31 claims
- 1376US6649606B1Tetrahydroisoquinoline analogs as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Nov 18, 2003·12 cites·12 claims
- 1474US6809102B2Cyano-substituted dihydropyrimidine compounds and their use to treat diseasesBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Oct 26, 2004·7 cites·32 claims
- 1574US6521759B2Aminothiazole inhibitors of cyclin dependent kinasesBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Feb 18, 2003·6 cites·1 claims
- 1673US8507672B2Substituted pyrrolo[2,3-d]pyrimidines as LIM kinase 2 inhibitorsHARRISON BRYCE ALDEN·Filed 2008·Granted Aug 13, 2013·2 cites·12 claims
- 1773US8193202B2LIMK2 inhibitors, compositions comprising them, and methods of their useBURGOON HUGH ALFRED·Filed 2009·Granted Jun 5, 2012·2 cites·7 claims
- 1872US9365602B2Sodium glucose co-transporter inhibitors and methods of their useHARRISON BRYCE ALDEN·Filed 2013·Granted Jun 14, 2016·1 cites·1 claims
- 1966US8450332B2LIMK2 inhibitors, compositions comprising them, and methods of their useBURGOON HUGH ALFRED·Filed 2012·Granted May 28, 2013·1 cites·7 claims
- 2062US2019099436A1Sodium glucose co-transporter inhibitors and methods of their useLEXICON PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 2157US2017087172A1Sodium glucose co-transporter inhibitors and methods of their useLEXICON PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 2240US2002165240A1Method of treating proliferative diseases using Eg5 inhibitorsFiled 2002·Application pending·0 cites
- 2338US2013059896A15-(1h-pyrazol-5-yl)thiazole-based compounds for the treatment of diseases and disorders of the eyeGOODWIN NICOLE CATHLEEN·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David Brent Rawlins files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →